These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23677863)

  • 1. Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background.
    Ramkumar HL; Tuo J; Shen DF; Zhang J; Cao X; Chew EY; Chan CC
    J Nutr; 2013 Jul; 143(7):1129-35. PubMed ID: 23677863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigment epithelium-derived factor reduces apoptosis and pro-inflammatory cytokine gene expression in a murine model of focal retinal degeneration.
    Wang Y; Subramanian P; Shen D; Tuo J; Becerra SP; Chan CC
    ASN Neuro; 2013 Nov; 5(5):e00126. PubMed ID: 24160756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone ameliorates retinal lesions in Ccl2/Cx3cr1 double-deficient mice via modulation of microglia.
    Shen D; Cao X; Zhao L; Tuo J; Wong WT; Chan CC
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):2897-904. PubMed ID: 21245403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group
    JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
    ; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
    Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
    Chew EY; Clemons TE; Agrón E; Launer LJ; Grodstein F; Bernstein PS;
    JAMA; 2015 Aug; 314(8):791-801. PubMed ID: 26305649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration.
    Tuo J; Bojanowski CM; Zhou M; Shen D; Ross RJ; Rosenberg KI; Cameron DJ; Yin C; Kowalak JA; Zhuang Z; Zhang K; Chan CC
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3827-36. PubMed ID: 17652758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model.
    Tuo J; Cao X; Shen D; Wang Y; Zhang J; Oh JY; Prockop DJ; Chan CC
    J Neuroinflammation; 2012 Mar; 9():59. PubMed ID: 22452753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    ; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
    JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signalling.
    Luhmann UF; Lange CA; Robbie S; Munro PM; Cowing JA; Armer HE; Luong V; Carvalho LS; MacLaren RE; Fitzke FW; Bainbridge JW; Ali RR
    PLoS One; 2012; 7(4):e35551. PubMed ID: 22545116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversial view of a genetically altered mouse model of focal retinal degeneration.
    Chu XK; Wang Y; Ardeljan D; Tuo J; Chan CC
    Bioengineered; 2013; 4(3):130-5. PubMed ID: 23196746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration.
    Tuo J; Ross RJ; Herzlich AA; Shen D; Ding X; Zhou M; Coon SL; Hussein N; Salem N; Chan CC
    Am J Pathol; 2009 Aug; 175(2):799-807. PubMed ID: 19608872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomics analysis of Ccl2/Cx3cr1/Crb1
    Badia A; Salas A; Duarri A; Ferreira-de-Souza B; Zapata MÁ; Fontrodona L; García-Arumí J
    Exp Eye Res; 2021 Feb; 203():108424. PubMed ID: 33373623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
    Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V
    JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.
    Aronow ME; Chew EY
    Curr Opin Ophthalmol; 2014 May; 25(3):186-90. PubMed ID: 24614146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.
    Huang LL; Coleman HR; Kim J; de Monasterio F; Wong WT; Schleicher RL; Ferris FL; Chew EY
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3864-9. PubMed ID: 18450596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Potential Therapies in a Mouse Model of Focal Retinal Degeneration with Age-related Macular Degeneration (AMD)-Like Lesions.
    Popp N; Chu XK; Shen D; Tuo J; Chan CC
    J Clin Exp Ophthalmol; 2013 Oct; 4(5):1000296. PubMed ID: 24432192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells.
    Bian Q; Gao S; Zhou J; Qin J; Taylor A; Johnson EJ; Tang G; Sparrow JR; Gierhart D; Shang F
    Free Radic Biol Med; 2012 Sep; 53(6):1298-307. PubMed ID: 22732187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration.
    Chan CC; Ross RJ; Shen D; Ding X; Majumdar Z; Bojanowski CM; Zhou M; Salem N; Bonner R; Tuo J
    Ophthalmic Res; 2008; 40(3-4):124-8. PubMed ID: 18421225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
    ; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
    JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.